EIM
GILD icon

Essex Investment Management’s Gilead Sciences GILD Stock Holding History

Essex Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-27,822
Closed -$1.94M – 414
2021
Q3 		$1.94M Buy
27,822
+85
+0.3% +$5.97K 0.24% 144
2021
Q2 		$1.91M Sell
27,737
-2,266
-8% -$151K 0.22% 154
2021
Q1 		$1.94M Sell
30,003
-2,163
-7% -$139K 0.24% 147
2020
Q4 		$1.87M Sell
32,166
-6,625
-17% -$400K 0.23% 142
2020
Q3 		$2.45M Sell
38,791
-599
-2% -$41.5K 0.35% 80
2020
Q2 		$3.03M Sell
39,390
-1,429
-4% -$110K 0.5% 54
2020
Q1 		$3.05M Buy
+40,819
New +$2.82M 0.62% 38
2018
Q4 		– Sell
-30,553
Closed -$2.36M – 497
2018
Q3 		$2.36M Sell
30,553
-28,434
-48% -$2.15M 0.28% 99
2018
Q2 		$4.18M Sell
58,987
-193
-0.3% -$13.6K 0.52% 47
2018
Q1 		$4.46M Buy
59,180
+35,080
+146% +$2.79M 0.59% 41
2017
Q4 		$1.73M Sell
24,100
-53,766
-69% -$4.08M 0.23% 137
2017
Q3 		$6.31M Buy
77,866
+62,750
+415% +$4.8M 0.86% 21
2017
Q2 		$1.07M Hold
15,116
– – 0.15% 192
2017
Q1 		$1.03M Hold
15,116
– – 0.16% 183
2016
Q4 		$1.08M Buy
15,116
+5,916
+64% +$440K 0.18% 145
2016
Q3 		$728K Sell
9,200
-100,798
-92% -$8.19M 0.12% 213
2016
Q2 		$9.18M Sell
109,998
-244
-0.2% -$21.7K 1.53% 14
2016
Q1 		$10.1M Sell
110,242
-32,859
-23% -$2.96M 1.74% 14
2015
Q4 		$14.5M Sell
143,101
-231
-0.2% -$24K 2.26% 6
2015
Q3 		$14.1M Buy
143,332
+17,410
+14% +$1.93M 2.31% 5
2015
Q2 		$14.7M Sell
125,922
-17,205
-12% -$1.88M 2.23% 5
2015
Q1 		$14M Sell
143,127
-54,327
-28% -$5.52M 1.97% 5
2014
Q4 		$18.6M Sell
197,454
-6,342
-3% -$656K 2.71% 1
2014
Q3 		$21.7M Sell
203,796
-3,705
-2% -$363K 3.32% 1
2014
Q2 		$17.2M Sell
207,501
-19,716
-9% -$1.53M 2.53% 1
2014
Q1 		$16.1M Sell
227,217
-1,416
-0.6% -$111K 2.34% 1
2013
Q4 		$17.2M Buy
228,633
+1,287
+0.6% +$89.6K 2.43% 1
2013
Q3 		$14.3M Sell
227,346
-21,645
-9% -$1.29M 2.17% 3
2013
Q2 		$12.8M Buy
+248,991
New +$13M 2.25% 3

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Essex Investment Management's GILD Position: Q4 2021 in Review

Essex Investment Management sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 27,822 shares — an estimated $1.94M sold.

Essex Investment Management first reported a position in GILD in Q2 2013 and held it in 29 quarters. The position peaked at $21.7M in Q3 2014. 1,683 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

  • Essex Investment Management reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
  • Essex Investment Management sold 27,822 Gilead Sciences shares in Q4 2021, an estimated $1.94M.
  • Essex Investment Management first reported a position in Gilead Sciences in Q2 2013 and held it in 29 quarters.
  • Essex Investment Management's Gilead Sciences position peaked at $21.7M in Q3 2014.
  • 1,683 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Essex Investment Management's 13F filing for Q4 2021, filed 10 Feb 2022.